Ray,
Sounds like you are (rightfully) quite proud of your daughter.
Any quick comparison of how this more generalized CAR-T therapy might compare to the “push/pull” cancer fighting strategies that Nektar Therapeutics (NKTR) seems to be working on with NKTR-214 and NKTR-262, in particular.
In case you happened to miss it, here is a link to an excellent thread from 10 days or so ago started by Motley Fool One’s Ted Yun on Nektar and their method of attacking cancer.
http://discussion.fool.com/nktr-nktr-214-deep-dive-33021896.aspx…
Shortly after that thread, Saul provided this concise post/thread about finally getting checkpoint inhibitors.
http://discussion.fool.com/okay-i-finally-get-checkpoint-inhibit…
Perhaps you or your daughter could have some insights? Is CAR-T more of a “cure cure”, but more expensive?
Thanks in advance,
volfan84
who is a mechanical engineer and a fan of systems, with tons unknown about biological systems